Ilex Medical Net Assets

Latest as of June 2026: ILA670.18 Million ILA ≈ $1.80 Million USD

Ilex Medical net assets. Based on the latest financial reports, Ilex Medical (ILX) has net assets worth ILA670.18 Million ILA (≈ $1.80 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA955.92 Million ≈ $2.56 Million USD) and total liabilities (ILA285.75 Million ≈ $766.08K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Ilex Medical (ILX) equity growth momentum to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	ILA670.18 Million
% of Total Assets	70.11%
Annual Growth Rate	11.39%
5-Year Change	18.96%
10-Year Change	180.04%
Growth Volatility	32.47

Net Assets of Ilex Medical (2008–2025)

Net assets of Ilex Medical from 2008 to 2025. This chart illustrates how Ilex Medical's net assets have evolved over time, based on quarterly financial data. See ILX equity to assets ratio to measure how much of total assets are equity-financed.

Annual Net Assets for Ilex Medical (2008–2025)

The table below shows the annual net assets of Ilex Medical from 2008 to 2025. For live market cap and overall valuation, see Ilex Medical market capitalisation.

Year	Net Assets	Change
2025-12-31	ILA684.71 Million ≈ $1.84 Million	+5.91%
2024-12-31	ILA646.49 Million ≈ $1.73 Million	+3.69%
2023-12-31	ILA623.51 Million ≈ $1.67 Million	+1.70%
2022-12-31	ILA613.10 Million ≈ $1.64 Million	+6.52%
2021-12-31	ILA575.57 Million ≈ $1.54 Million	+29.77%
2020-12-31	ILA443.54 Million ≈ $1.19 Million	+37.12%
2019-12-31	ILA323.48 Million ≈ $867.23K	+10.22%
2018-12-31	ILA293.49 Million ≈ $786.83K	+10.27%
2017-12-31	ILA266.15 Million ≈ $713.53K	+8.85%
2016-12-31	ILA244.51 Million ≈ $655.52K	+8.19%
2015-12-31	ILA225.99 Million ≈ $605.87K	+10.45%
2014-12-31	ILA204.60 Million ≈ $548.53K	-4.56%
2013-12-31	ILA214.38 Million ≈ $574.74K	-17.53%
2012-12-31	ILA259.96 Million ≈ $696.93K	-8.14%
2011-12-31	ILA282.99 Million ≈ $758.68K	+134.26%
2010-12-31	ILA120.80 Million ≈ $323.87K	-5.12%
2009-12-31	ILA127.32 Million ≈ $341.33K	+16.33%
2008-12-31	ILA109.44 Million ≈ $293.42K	--

Equity Component Analysis

This analysis shows how different components contribute to Ilex Medical's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 566.1% over the analyzed period, indicating profitable operations and earnings retention.

Ilex Medical Net Assets Breakdown (December 2025)

Ilex Medical net assets breakdown by equity component as of December 2025.

Component	Amount	Percentage
Retained Earnings	ILA610.80 Million	89.20%
Common Stock	ILA12.48 Million	1.82%
Other Comprehensive Income	ILA-79.85 Million	-11.66%
Other Components	ILA141.29 Million	20.64%
Total Equity	ILA684.71 Million	100.00%

Ilex Medical Competitors by Market Cap

The table below lists competitors of Ilex Medical ranked by their market capitalization.

Company	Market Cap
Bisalloy Steel Group Ltd AU:BIS	$140.15 Million
Affinity Bancshares Inc NASDAQ:AFBI	$140.18 Million
Prelude Therapeutics Inc NASDAQ:PRLD	$140.19 Million
CSG Holding Co Ltd SHE:200012	$140.20 Million
TYM Corporation KO:002900	$140.13 Million
Batulicin Nusantara Maritim Tbk PT JK:BESS	$140.11 Million
TerrAscend Corp F:TED	$140.06 Million
D-Box Technologies Inc. TO:DBO	$140.06 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Ilex Medical's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 646,487,000 to 684,714,000, a change of 38,227,000 (5.9%).
Net income of 55,555,000 contributed positively to equity growth.
Dividend payments of 13,643,000 reduced retained earnings.
Other comprehensive income decreased equity by 3,995,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	ILA55.55 Million	+8.11%
Dividends Paid	ILA13.64 Million	-1.99%
Other Comprehensive Income	ILA-4.00 Million	-0.58%
Other Changes	ILA310.00K	+0.05%
Total Change	ILA-	5.91%

Book Value vs Market Value Analysis

This analysis compares Ilex Medical's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 76.50x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 541.56x to 76.50x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2013-12-31	ILA8.63	ILA4672.00	x
2014-12-31	ILA9.16	ILA4672.00	x
2015-12-31	ILA11.93	ILA4672.00	x
2016-12-31	ILA14.06	ILA4672.00	x
2017-12-31	ILA16.18	ILA4672.00	x
2018-12-31	ILA18.92	ILA4672.00	x
2019-12-31	ILA22.20	ILA4672.00	x
2020-12-31	ILA41.57	ILA4672.00	x
2021-12-31	ILA51.02	ILA4672.00	x
2022-12-31	ILA54.36	ILA4672.00	x
2023-12-31	ILA55.72	ILA4672.00	x
2024-12-31	ILA57.87	ILA4672.00	x
2025-12-31	ILA61.07	ILA4672.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Ilex Medical utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 8.11%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 5.97%
• Asset Turnover: 0.94x
• Equity Multiplier: 1.45x
Recent ROE (8.11%) is below the historical average (18.07%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2008	17.00%	8.75%	1.25x	1.55x	ILA7.67 Million
2009	23.66%	12.30%	1.27x	1.52x	ILA17.39 Million
2010	23.88%	11.67%	1.29x	1.59x	ILA16.77 Million
2011	23.36%	7.60%	0.63x	4.91x	ILA18.71 Million
2013	-25.66%	-4.81%	0.86x	6.17x	ILA-30.87 Million
2014	24.05%	5.11%	0.85x	5.51x	ILA12.91 Million
2015	25.99%	6.25%	1.03x	4.02x	ILA19.14 Million
2016	19.60%	5.33%	1.06x	3.46x	ILA13.54 Million
2017	23.04%	6.76%	1.14x	2.99x	ILA21.17 Million
2018	24.75%	7.82%	1.13x	2.81x	ILA28.00 Million
2019	27.05%	9.50%	1.09x	2.61x	ILA37.98 Million
2020	27.20%	12.74%	1.21x	1.76x	ILA76.27 Million
2021	34.31%	18.61%	1.21x	1.52x	ILA139.92 Million
2022	16.66%	11.70%	0.97x	1.47x	ILA40.81 Million
2023	8.16%	5.47%	0.92x	1.63x	ILA-11.47 Million
2024	6.03%	4.24%	0.93x	1.54x	ILA-25.67 Million
2025	8.11%	5.97%	0.94x	1.45x	ILA-12.92 Million

Industry Comparison

This section compares Ilex Medical's net assets metrics with peer companies in the Medical Distribution industry.

Industry Context

Industry: Medical Distribution
Average net assets among peers: $382,143,000
Average return on equity (ROE) among peers: 10.35%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Ilex Medical (ILX)	ILA670.18 Million	17.00%	0.43x	$140.14 Million
Novolog Pharm-Up 1966 Ltd (NVLG)	$382.14 Million	10.35%	6.95x	$114.78 Million

About Ilex Medical

TA:ILX Israel Medical Distribution

Market Cap

$140.14 Million

ILA52.27 Billion ILA

Market Cap Rank

#17724 Global

#223 in Israel

Share Price

ILA4672.00

Change (1 day)

+4.36%

52-Week Range

ILA4303.00 - ILA7080.00

All Time High

ILA15645.73